{
    "type": "ETP",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "replication_method": "synthetic",
    "ucits": false,
    "complex_factors": [
        "Leverage",
        "Inverse Exposure",
        "Compounding Effect",
        "High Risk Profile",
        "Sophisticated Investor Requirement"
    ],
    "classification": "complex",
    "supporting_data": "The ETP is a -3x inverse leveraged product tracking the Solactive Magnificent 7 Index, using synthetic replication via derivatives and swaps. It has a high risk rating (7/7), no capital protection, and is intended only for sophisticated investors. The compounding effect and daily rebalancing introduce significant complexity, and the product explicitly states it is 'not simple and may be difficult to understand.' The lack of UCITS compliance and the presence of counterparty risk further contribute to its complexity.",
    "confidence": 95
}